Vimarsana
Biggest News Aggregation in the World

Real World Setting News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Real World Setting. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Real World Setting Today - Breaking & Trending Today

Study Reveals Key Insights on 5-Year Retention Rate, Efficacy of Secukinumab for Psoriasis Patients - Vimarsana News

Study Reveals Key Insights on 5-Year Retention Rate, Efficacy of Secukinumab for Psoriasis Patients

The multi-center study led to several important findings, one of which being that history of biologic-use could be a factor of importance in secukinumab retention prediction.

A Skeptical Review of Religious Prosociality Research - Vimarsana News

A Skeptical Review of Religious Prosociality Research

It should come as no surprise to readers that the general public overwhelmingly assumes that religion is tied to morality. This can be de scribed as the “Religion Makes You Good" theory. In more scientific terms, this “religious prosociality hypothesis" predicts that religious belief i ...

Tildrakizumab Linked With HRQOL Improvement in Psoriasis in a Real-World Setting - Vimarsana News

Tildrakizumab Linked With HRQOL Improvement in Psoriasis in a Real-World Setting

Strict inclusion and exclusion criteria in clinical trials means findings on health-related quality of life (HRQOL) may not be generalizable to the real-world setting.

Source: ajmc.com
Ixekizumab, Other Anti-IL-17A Biologics Led to Patient-Reported Improvements in Psoriasis Symptoms - Vimarsana News

Ixekizumab, Other Anti-IL-17A Biologics Led to Patient-Reported Improvements in Psoriasis Symptoms

New data suggests that anti-IL-17A biologics including ixekizumab showed strong self-reported results in signs and symptoms for psoriasis patients.

Photocure: New data presented at EAU 2023 highlight the effects of blue light cystoscopy in bladder cancer - Vimarsana News

Photocure: New data presented at EAU 2023 highlight the effects of blue light cystoscopy in bladder cancer

/PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces its participation in the congress, and two abstract presentations at the...